LG Chem, Ltd.

It is a time of challenges and uncertainties for the global biopharma industry and with the start of the second Trump Administration in the US, the international trade environment looks set to change

Drug approvals in South Korea fell in calendar 2023 amid the shift of COVID-19 to endemic from pandemic status, as domestic pharma firms began to shift their focus back to normalized R&D activities af

As the industry awaits the potential first approval of a metabolic-associated steatohepatitis (MASH) drug on 14 March, Ionis Pharmaceuticals, Inc. may have worked its way into the race to follow Ma

AVEO Oncology, also known as AVEO Pharmaceuticals, Inc. , has begun to enrol patients in a Phase III clinical trial evaluating its candidate ficlatuzumab in combination with Erbitux (cetuximab) in pa